Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Floris

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Rheumatology|March 12, 2016
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levelsMatteo Piga, Fiammetta Pesella, Maria Luisa Corraine, et al.
Arthritis Research & Therapy|November 12, 2017
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosusMatteo Piga, Alberto Floris, Giulia Cappellazzo, et al.
Arthritis Care & Research|October 11, 2019
Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early DamageAlberto Floris, Matteo Piga, Daniela Perra, et al.
Mediators of Inflammation|April 20, 2018
Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus ErythematosusAlberto Floris, Matteo Piga, Arduino Aleksander Mangoni, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 17, 2021
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature ReviewElisabetta Chessa, Matteo Piga, Alberto Floris, et al.
Autoimmunity Reviews|May 21, 2014
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohortMatteo Piga, Elisabetta Chessa, Valentina Ibba, et al.
The Journal of Rheumatology|February 15, 2024
Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature ReviewElisabetta Chessa, Alberto Floris, Mattia Congia, et al.
Rheumatology International|July 27, 2015
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012Matteo Piga, Laura Casula, Silvia Sanna, et al.
Frontiers in Immunology|February 27, 2026
Rationale for investigating the use of anifrolumab in neuropsychiatric systemic lupus erythematosus: a combined narrative and case-based systematic literature reviewElisabetta Chessa, Fabio Congiu, Giulia Rizzo, et al.
Open Access Rheumatology : Research and Reviews|March 11, 2021
Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic ArthritisMaria Maddalena Angioni, Alberto Floris, Ignazio Cangemi, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|March 12, 2016
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levelsMatteo Piga, Fiammetta Pesella, Maria Luisa Corraine, et al.
Arthritis Research & Therapy|November 12, 2017
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosusMatteo Piga, Alberto Floris, Giulia Cappellazzo, et al.
Arthritis Care & Research|October 11, 2019
Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early DamageAlberto Floris, Matteo Piga, Daniela Perra, et al.
Mediators of Inflammation|April 20, 2018
Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus ErythematosusAlberto Floris, Matteo Piga, Arduino Aleksander Mangoni, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 17, 2021
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature ReviewElisabetta Chessa, Matteo Piga, Alberto Floris, et al.
Autoimmunity Reviews|May 21, 2014
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: systematic literature review and analysis of a monocentric cohortMatteo Piga, Elisabetta Chessa, Valentina Ibba, et al.
The Journal of Rheumatology|February 15, 2024
Psychometric Properties of Patient Global Assessment in Psoriatic Arthritis: A Systematic Literature ReviewElisabetta Chessa, Alberto Floris, Mattia Congia, et al.
Rheumatology International|July 27, 2015
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001-2012Matteo Piga, Laura Casula, Silvia Sanna, et al.
Frontiers in Immunology|February 27, 2026
Rationale for investigating the use of anifrolumab in neuropsychiatric systemic lupus erythematosus: a combined narrative and case-based systematic literature reviewElisabetta Chessa, Fabio Congiu, Giulia Rizzo, et al.
Open Access Rheumatology : Research and Reviews|March 11, 2021
Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic ArthritisMaria Maddalena Angioni, Alberto Floris, Ignazio Cangemi, et al.
Pageof 7